Castleview Partners’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-242
| Closed | -$10.3K | – | 589 |
|
|
2024
Q4 | $10.3K | Hold |
242
| – | – | 0.01% | 575 |
|
|
2024
Q3 | $10.7K | Hold |
242
| – | – | 0.01% | 536 |
|
|
2024
Q2 | $9.63K | Hold |
242
| – | – | 0.01% | 534 |
|
|
2024
Q1 | $10.4K | Hold |
242
| – | – | 0.01% | 537 |
|
|
2023
Q4 | $10.1K | Hold |
242
| – | – | 0.01% | 512 |
|
|
2023
Q3 | $9.62K | Hold |
242
| – | – | 0.01% | 431 |
|
|
2023
Q2 | $9.92K | Hold |
242
| – | – | 0.01% | 434 |
|
|
2023
Q1 | $9.92K | Hold |
242
| – | – | 0.01% | 425 |
|
|
2022
Q4 | $9.91K | Hold |
242
| – | – | 0.01% | 372 |
|
|
2022
Q3 | $10K | Buy |
242
+238
| +5,950% | +$9.84K | 0.01% | 385 |
|
|
2022
Q2 | $174 | Sell |
4
-238
| -98% | -$10.4K | ﹤0.01% | 744 |
|
|
2022
Q1 | $10K | Sell |
242
-10,926
| -98% | -$451K | 0.01% | 503 |
|
|
2021
Q4 | $242 | Buy |
+11,168
| New | +$242 | ﹤0.01% | 641 |
|
|
2021
Q2 | $13K | Buy |
+242
| New | +$13K | 0.01% | 642 |
|